You are here

AstraZeneca starts new Covid-19 prevention trials of antibody cocktail

nz_astrazeneca_211147.jpg
AstraZeneca started late-stage trials on Saturday of an experimental long-acting monoclonal antibody combination drug it hopes could be used as a so-called prophylactic to prevent Covid-19 infection in at-risk people for up to 12 months.

[LONDON] AstraZeneca started late-stage trials on Saturday of an experimental long-acting monoclonal antibody combination drug it hopes could be used as a so-called prophylactic to prevent Covid-19 infection in at-risk people for up to 12 months.

The Phase III international clinical trial...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes